Skip NavigationSkip to Content

IL-7-induced phosphorylation of the adaptor Crk-like and other targets

  1. Author:
    Aiello, Francesca
    Guszczynski, Tad
    Li, Wenqing
    Jiang, Qiong
    Hodge, Deborah
    Massignan, Tania
    Di Lisio, Chiara
    Merchand, Anand
    Procopio, Antonio D
    Bonetto, Valentina
    Durum, Scott
  2. Author Address

    Cancer and Inflammation Program, CCR, NCI, NIH, Bldg 560, Frederick, MD 21702, USA. Electronic address: fbaiello@unich.it., Molecular Targets Laboratory, FCRDC, Bldg 560, Frederick, MD 21702, USA. Electronic address: Tad.guszczynski@mail.nih.gov., Cancer and Inflammation Program, CCR, NCI, NIH, Bldg 560, Frederick, MD 21702, USA. Electronic address: liwenq@mail.nih.gov., Cancer and Inflammation Program, CCR, NCI, NIH, Bldg 560, Frederick, MD 21702, USA. Electronic address: qiong.jiang@qiagen.com., Laboratory of Experimental Medicine, FCRDC, Bldg 560, Frederick, MD 21702, USA. Electronic address: hodged@mail.nih.gov., Dulbecco Telethon Institute, IRCCS-Istituto di Ricerche Farmacologiche M. Negri, via La Masa 19, 20156 Milano, Italy., Cancer and Inflammation Program, CCR, NCI, NIH, Bldg 560, Frederick, MD 21702, USA. Electronic address: chiara.dilisio@unich.it., Center for Cancer Research, NIH, Bethesda, MD 20892, USA. Electronic address: anand.merchant@nih.gov., Department of Clinical and Medical Sciences, Marche Polytechnic University, via Tronto 10, 60100 Ancona, Italy. Electronic address: a.d.procopio@univpm.it., Dulbecco Telethon Institute, IRCCS-Istituto di Ricerche Farmacologiche M. Negri, via La Masa 19, 20156 Milano, Italy. Electronic address: valentina.bonetto@marionegri.it., Cancer and Inflammation Program, CCR, NCI, NIH, Bldg 560, Frederick, MD 21702, USA. Electronic address: durums@mail.ncifcrf.gov.,
    1. Year: 2018
    2. Date: Mar 23
    3. Epub Date: 2018 03 23
  1. Journal: Cellular Signalling
    1. Pages: pii: S0898-6568(18)30073-1
  2. Type of Article: Article
  1. Abstract:

    IL-7 is required for T cell differentiation and mature T cell homeostasis and promotes pro-B cell proliferation and survival. Tyrosine phosphorylation plays a central role in IL-7 signaling. We identified by two-dimensional electrophoresis followed by anti-phosphotyrosine immunoblotting and mass spectrometry sixteen tyrosine phosphorylated proteins from the IL-7-dependent cell line D1. IL-7 stimulation induced the phosphorylation of the proteins STI1, ATIC and hnRNPH, involved in pathways related to survival, proliferation and gene expression, respectively, and increased the phosphorylation of CrkL, a member of a family of adaptors including the highly homologous Crk isoforms CrkII and CrkI, important in multiple signaling pathways. We observed an increased phosphorylation of CrkL in murine pro-B cells and in murine and human T cells. In addition, IL-7 increased the association of CrkL with the transcription factor Stat5, essential for IL-7 pro-survival activity. The selective tyrosine kinase inhibitor Imatinib. counteracted the IL-7 pro-survival effect in D1 cells and decreased CrkL phosphorylation. These data suggested that CrkL could play a pro-survival role in IL-7-mediated signaling. We observed that pro-B cells also expressed, in addition to CrkL, the Crk isoforms CrkII and CrkI and therefore utilized pro-B cells conditionally deficient in all three to evaluate the role of these proteins. The observation that the IL-7 pro-survival effect was reduced in Crk/CrkL conditionally-deficient pro-B cells further pointed to a pro-survival role of these adaptors. To further evaluate the role of these proteins, gene expression studies were performed in Crk/CrkL conditionally-deficient pro-B cells. IL-7 decreased the transcription of the receptor LAIR1, which inhibits B cell proliferation, in a Crk/CrkL-dependent manner, suggesting that the Crk family of proteins may promote pro-B cell proliferation. Our data contribute to the understanding of IL-7 signaling and suggest the involvement of Crk family proteins in pathways promoting survival and proliferation. Copyright © 2017. Published by Elsevier Inc.

    See More

External Sources

  1. DOI: 10.1016/j.cellsig.2018.03.008
  2. PMID: 29581031
  3. PII : S0898-6568(18)30073-1

Library Notes

  1. Fiscal Year: FY2017-2018
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel